Search - tctmd.com

Displaying 81 - 91 of 91

Sort: Relevancy | Date

News Daily News

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

Yael L. Maxwell

January 01, 2014

News Conference News ESC 2013

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

Caitlin E. Cox

September 02, 2013

News Conference News ACC 2013

ULTIMA: Ultrasound Accelerated Thrombolysis Shows Promise for Pulmonary Embolism

L.A. McKeown

March 08, 2013

News Daily News

La Terapia Endovascular contra la TVP parece Segura y Efectiva en los Registros

January 22, 2013

News Daily News

Endovascular Therapy for DVT Appears Safe, Effective in Registries

January 22, 2013

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Daily News

Catheter-Directed Thrombolysis Beneficial for Proximal DVT

Yael L. Maxwell

December 12, 2011

News Industry News

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

September 08, 2011

News Daily News

Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT

Caitlin E. Cox

May 06, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

January 04, 2011

Advertisement

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

ULTIMA: Ultrasound Accelerated Thrombolysis Shows Promise for Pulmonary Embolism

La Terapia Endovascular contra la TVP parece Segura y Efectiva en los Registros

Endovascular Therapy for DVT Appears Safe, Effective in Registries

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

Catheter-Directed Thrombolysis Beneficial for Proximal DVT

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content